SCHEMBL13660463

SCHEMBL13660463

O=c1c2ncccc2nc([C@H]2C[C@@H](C(F)(F)F)C2)n1-c1ccc(Cl)nc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 2/20 0.37
HRH3 Q9Y5N1 1/20 0.37
PDE4D Q08499 1/20 0.37
USP14 P54578 1/20 0.37
MAT2A P31153 3/20 0.33
USP1 O94782 1/20 0.33
PIM2 Q9P1W9 1/20 0.31
POLB P06746 1/20 0.31
NPC1 O15118 1/20 0.31
MAPT P10636 1/20 0.31
RAB9A P51151 1/20 0.31
CHRNB2 P17787 1/20 0.31
CHRNA4 P43681 1/20 0.31
CHRNB4 P30926 1/20 0.30
CHRNA3 P32297 1/20 0.30
CXCR3 P49682 1/20 0.30
IDO1 P14902 1/20 0.30
TDO2 P48775 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3174425 0.92 PDE4B (0.36) PDE4BHRH3PDE4DUSP14MAT2A
SCHEMBL3174423 0.92 PDE4B (0.36) PDE4BHRH3PDE4DUSP14MAT2A
SCHEMBL13660456 0.90 HRH3 (0.40) PDE4BHRH3PDE4DUSP14MAT2A
SCHEMBL13660312 0.86 PDE4B (0.43) PDE4BHRH3PDE4DUSP14MAT2A
SCHEMBL13660461 0.86 HRH3 (0.37) PDE4BHRH3PDE4DUSP14MAT2A
SCHEMBL13660307 0.81 HRH3 (0.41) PDE4BHRH3PDE4DUSP14MAT2A
SCHEMBL3185951 0.80 PDE4B (0.39) PDE4BHRH3PDE4DUSP14MAPT
SCHEMBL3185944 0.80 PDE4B (0.39) PDE4BHRH3PDE4DUSP14MAPT
SCHEMBL3169708 0.78 PDE4B (0.44) PDE4BHRH3PDE4DUSP14
SCHEMBL3169713 0.78 PDE4B (0.44) PDE4BHRH3PDE4DUSP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009121036-A2 SUBSTITUTED ARYL PYRIMIDINONE DERIVATIVES NEUROGEN CORPORATION (US) 2009-10-01 WO disclosed